Table 3 Scaled up program pathways by outcomes
Outcome | Type I Comprehensive % (N) | Type II Efficacy omitter % (N) | Type III Trial omitter % (N) | Type IV At scale dissemination % (N) | Total (all programs) % (N) |
|---|---|---|---|---|---|
Institutionalised | 36.4 (8) | 0.0 (0) | 50.0 (5) | 66.7 (4) | 42.5 (17) |
Institutionalised & Adapted | 13.6 (3) | 50.0 (1) | 0.0 (0) | 0.0 (0) | 10.0 (4) |
Institutionalised & Commercialised | 4.5 (1) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 2.5 (1) |
Commercialised | 22.7 (5) | 0.0 (0) | 20.0 (2) | 16.7 (1) | 20.0 (8) |
Adapted | 9.1 (2) | 0.0 (0) | 0.0 (0) | 0.0 (0) | 5.0 (2) |
Unknown | 13.6 (3) | 50.0 (1) | 30.0 (3) | 16.7 (1) | 20.0 (8) |
Total | 100.0 (22) | 100.0 (2) | 100.0 (10) | 100.0 (6) | 100.0 (40) |